Home Tags Rare

Rare

Takeda Drug Fails Pivotal Assessments in 2 Uncommon Epilepsies; Path Ahead Relies on Regulatory Flexibility

Takeda Drug Fails Pivotal Assessments in 2 Uncommon Epilepsies; Path Ahead...

Robert Day -
Challenges in Conducting Financial Evaluations for Orphan Medicine in Uncommon Illnesses – Healthcare Economist

Challenges in Conducting Financial Evaluations for Orphan Medicine in Uncommon Illnesses...

Robert Day -
European Fee Determination Is a Reprieve for PTC Therapeutics’ Uncommon Muscle Illness Drug

European Fee Determination Is a Reprieve for PTC Therapeutics’ Uncommon Muscle...

Robert Day -
12Page 2 of 2
©